Asian Annals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Simon R Knight
Siven Seevanayagam
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clarke, C. P
Right arrow Articles by Seevanayagam, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarke, C. P
Right arrow Articles by Seevanayagam, S.
Related Collections
Right arrow Lung - cancer
Asian Cardiovasc Thorac Ann 2006;14:206-209
© 2006 Asia Publishing EXchange Ltd


ORIGINAL CONTRIBUTIONS

Management of Malignant Mesothelioma by Decortication and Adjunct Phototherapy

Charles P Clarke, MBBS, Simon R Knight, MBBS, Freddy J Daniel, MBMS, Siven Seevanayagam, MBBS

Austin Health, Heidelberg, Victoria, Australia

For reprint information contact: CP Clarke, MBBS Tel: 61 3 9419 2477 Fax: 61 3 9417 1694 Email: clarkecp{at}bigpond.com.au, Level 5, 55 Victoria Parade, Fitzroy, Victoria 3065, Australia.

Malignant mesothelioma is a relatively rare tumor that originates in the pleural space and almost invariably results from exposure to asbestos. Between September 1989 and December 1999, 100 patients were managed with curative intent using a combination of full decortication, adjunct phototherapy after administration of hematoporphyrin derivative, and strip radiotherapy to any areas where adequate clearance was not obtained. The survival curve was compared to that of 17 matched patients treated by decortication alone. Median survival increased from 250 to 440 days in the combined treatment group.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by SAGE Publications